NeuroMetrix, Inc. (NURO)
May 1, 2025 - NURO was delisted (reason: acquired by ECOR)
4.580
0.00 (0.00%)
Inactive · Last trade price on May 1, 2025
NeuroMetrix Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 1.43 | 1.73 | 4.34 | 22.57 | 5.23 |
Short-Term Investments | 11.67 | 16.27 | 16.86 | - | - |
Cash & Short-Term Investments | 13.1 | 18 | 21.2 | 22.57 | 5.23 |
Cash Growth | -27.24% | -15.11% | -6.08% | 331.90% | 67.17% |
Accounts Receivable | 0.19 | 0.52 | 0.65 | 0.31 | 0.33 |
Receivables | 0.19 | 0.52 | 0.65 | 0.31 | 0.33 |
Inventory | 1.35 | 1.56 | 1.61 | 0.71 | 1.05 |
Prepaid Expenses | 0.38 | 0.78 | 0.65 | 0.6 | 0.48 |
Total Current Assets | 15.01 | 20.85 | 24.11 | 24.19 | 7.09 |
Property, Plant & Equipment | 0.31 | 0.54 | 0.54 | 0.67 | 0.88 |
Other Long-Term Assets | - | 0.03 | 0.03 | 0.03 | 0.03 |
Total Assets | 15.32 | 21.42 | 24.67 | 24.89 | 7.99 |
Liabilities
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 0.36 | 0.22 | 0.37 | 0.28 | 0.14 |
Accrued Expenses | 0.54 | 0.87 | 0.57 | 0.82 | 0.95 |
Current Portion of Leases | 0.11 | 0.15 | 0.15 | 0.23 | 0.6 |
Other Current Liabilities | 0.01 | 0.01 | 0.02 | 0.03 | 0.59 |
Total Current Liabilities | 1.01 | 1.24 | 1.11 | 1.37 | 2.29 |
Long-Term Leases | - | 0.09 | 0.21 | 0.31 | 0.46 |
Total Liabilities | 1.01 | 1.33 | 1.31 | 1.67 | 2.75 |
Shareholders' Equity
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Common Stock | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 232.17 | 229.96 | 226.94 | 222.38 | 202.13 |
Retained Earnings | -217.92 | -210.11 | -203.58 | -199.16 | -196.88 |
Comprehensive Income & Other | 0.06 | 0.24 | - | - | - |
Total Common Equity | 14.31 | 20.09 | 23.36 | 23.22 | 5.25 |
Shareholders' Equity | 14.31 | 20.09 | 23.36 | 23.22 | 5.25 |
Total Liabilities & Equity | 15.32 | 21.42 | 24.67 | 24.89 | 7.99 |
Additional Metrics
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Total Debt | 0.11 | 0.24 | 0.36 | 0.54 | 1.06 |
Net Cash (Debt) | 12.99 | 17.76 | 20.84 | 22.04 | 4.17 |
Net Cash Growth | -26.86% | -14.81% | -5.41% | 429.07% | 156.95% |
Net Cash Per Share | 6.59 | 17.04 | 23.43 | 34.49 | 11.05 |
Filing Date Shares Outstanding | 2.06 | 1.99 | 0.97 | 0.87 | 0.47 |
Total Common Shares Outstanding | 2.05 | 1.52 | 0.97 | 0.84 | 0.47 |
Working Capital | 14 | 19.61 | 23 | 22.82 | 4.8 |
Book Value Per Share | 6.98 | 13.18 | 24.00 | 27.80 | 11.07 |
Tangible Book Value | 14.31 | 20.09 | 23.36 | 23.22 | 5.25 |
Tangible Book Value Per Share | 6.98 | 13.18 | 24.00 | 27.80 | 11.07 |
Machinery | 0.96 | 0.96 | 0.79 | 1.44 | 1.36 |
Leasehold Improvements | 0.07 | 0.07 | 0.06 | 0.07 | 0.14 |